Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2008 2
2012 1
2016 2
2017 3
2018 4
2019 10
2020 5
2021 10
2022 12
2023 7
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Real-world retrospective study of prostate-specific antigen and safety assessment with darolutamide plus androgen deprivation therapy for metastasis hormone-sensitive prostate cancer.
Liu J, Wang S, Yang Y, Wang S, Campobasso D, Tan YG, Gao Q, Yang L, Cao Y, Ji Y, Du P, Zhang B. Liu J, et al. Among authors: cao y. Transl Androl Urol. 2024 Mar 31;13(3):433-441. doi: 10.21037/tau-24-96. Epub 2024 Mar 25. Transl Androl Urol. 2024. PMID: 38590967 Free PMC article.
Construction of functional neural network tissue combining CBD-NT3-modified linear-ordered collagen scaffold and TrkC-modified iPSC-derived neural stem cells for spinal cord injury repair.
Wu Z, Zhou Y, Hou X, Liu W, Yin W, Wang L, Cao Y, Jiang Z, Guo Y, Chen Q, Xie W, Wang Z, Shi N, Liu Y, Gao X, Luo L, Dai J, Ren C, Jiang X. Wu Z, et al. Among authors: cao y. Bioact Mater. 2024 Feb 3;35:242-258. doi: 10.1016/j.bioactmat.2024.01.012. eCollection 2024 May. Bioact Mater. 2024. PMID: 38333615 Free PMC article.
Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma.
Zhou Y, Cao Y, Liu W, Wang L, Kuang Y, Zhou Y, Chen Q, Cheng Z, Huang H, Zhang W, Jiang X, Wang B, Ren C. Zhou Y, et al. Among authors: cao y. Front Immunol. 2023 Dec 15;14:1294459. doi: 10.3389/fimmu.2023.1294459. eCollection 2023. Front Immunol. 2023. PMID: 38162649 Free PMC article.
63 results